Home/Filings/4/0001104659-24-068411
4//SEC Filing

Litchman Manuel MD 4

Accession 0001104659-24-068411

CIK 0001680048other

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 8:35 PM ET

Size

5.0 KB

Accession

0001104659-24-068411

Insider Transaction Report

Form 4
Period: 2024-05-31
Litchman Manuel MD
DirectorPresident, CEO and Interim CFO
Transactions
  • Tax Payment

    Common Stock

    2024-05-31$0.35/sh1,396$48983,024 total
Footnotes (2)
  • [F1]1,396 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units.
  • [F2]Includes 5,000 shares of common stock acquired under the Mustang Bio, Inc. Employee Stock Purchase Plan on March 1, 2024.

Issuer

MUSTANG BIO, INC.

CIK 0001680048

Entity typeother

Related Parties

1
  • filerCIK 0001709485

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 8:35 PM ET
Size
5.0 KB